Intervention Review

TPO receptor agonist for chronic idiopathic thrombocytopenic purpura

  1. Yan Zeng2,†,
  2. Xin Duan1,*,
  3. Jiajun Xu3,
  4. Xun Ni2

Editorial Group: Cochrane Haematological Malignancies Group

Published Online: 6 JUL 2011

Assessed as up-to-date: 4 MAY 2010

DOI: 10.1002/14651858.CD008235.pub2


How to Cite

Zeng Y, Duan X, Xu J, Ni X. TPO receptor agonist for chronic idiopathic thrombocytopenic purpura. Cochrane Database of Systematic Reviews 2011, Issue 7. Art. No.: CD008235. DOI: 10.1002/14651858.CD008235.pub2.

Author Information

  1. 1

    West China Hospital, Sichuan University, Department of Orthopaedic Surgery, Chengdu, Sichuan, China

  2. 2

    West China Hospital, Sichuan University, Department of Hematology, Chengdu, Sichuan, China

  3. 3

    West China Hospital, Sichuan University, Mental Health Centre, Chengdu, Sichuan, China

  1. Yan Zeng and Xin Duan contributed equally to this review. Yan Zeng is co-contact author to this review.

*Xin Duan, Department of Orthopaedic Surgery, West China Hospital, Sichuan University, No. 37, Guo Xue Xiang, Chengdu, Sichuan, 610041, China. dxbaal@hotmail.com. dxbaal@sina.com, Dxbaal@yahoo.com.

Publication History

  1. Publication Status: New
  2. Published Online: 6 JUL 2011

SEARCH

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Francesco Rodeghiero, Marco Ruggeri, ITP and international guidelines: What do we know, what do we need?, La Presse Médicale, 2014, 43, 4, e61

    CrossRef

  2. 2
    Francesco Rodeghiero, Roberto Stasi, Aristoteles Giagounidis, Jean-François Viallard, Bertrand Godeau, Ingrid Pabinger, Douglas Cines, Howard Liebman, Xuena Wang, Paul Woodard, Long-term safety and tolerability of romiplostim in patients with primary immune thrombocytopenia: a pooled analysis of 13 clinical trials, European Journal of Haematology, 2013, 91, 5
  3. 3
    Bahareh Ghadaki, Ishac Nazi, John G. Kelton, Donald M. Arnold, Sustained remissions of immune thrombocytopenia associated with the use of thrombopoietin receptor agonists, Transfusion, 2013, 53, 11
  4. 4
    Donald M. Arnold, Platelet count or bleeding as the outcome in ITP trials?, American Journal of Hematology, 2012, 87, 10
  5. 5
    Francesco Rodeghiero, TPO-receptor agonists in ITP: A clinician's navigation between scylla and charybdis, American Journal of Hematology, 2012, 87, 10
  6. 6
    Samir Dalia, Benjamin Djulbegovic, Acute and Chronic Immune Thrombocytopenia: Biology, Diagnosis, and Management,
  7. 7
    Lise J Estcourt, Richard Gregg, Simon Stanworth, Carolyn Doree, Marialena Trivella, Michael F Murphy, Alan Tinmouth, Alternative agents versus prophylactic platelet transfusion for preventing bleeding in patients with haematological disorders after chemotherapy or stem cell transplantation, The Cochrane Library,
  8. 8
    Helga Dodillet, Nicole Skoetz, Karl-Anton Kreuzer, Ina Monsef, Andreas Engert, Kathrin Bauer, Thrombopoietin mimetics for patients with myelodysplastic syndromes, The Cochrane Library,